What are the diagnostic criteria for gestational diabetes mellitus (GDM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Gestational Diabetes Mellitus

Two diagnostic strategies exist for GDM, and you can use either the one-step approach (75g OGTT with any single abnormal value) or the two-step approach (50g screening followed by 100g OGTT with two abnormal values), both performed at 24-28 weeks of gestation. 1

Timing of Screening

  • Screen all pregnant women at 24-28 weeks of gestation unless they have already been diagnosed with overt diabetes 1, 2
  • Test immediately at the first prenatal visit if high-risk features are present: marked obesity (BMI ≥30 kg/m²), previous GDM history, glucosuria, strong family history of diabetes, or high-risk ethnicity (Asian, Hispanic, African American, Native American, Pacific Islander) 1, 2, 3
  • If early screening is negative in high-risk women, repeat testing at 24-28 weeks 1, 4

One-Step Approach (IADPSG Criteria)

Perform a 75g oral glucose tolerance test after an overnight fast of at least 8 hours, measuring plasma glucose at fasting, 1 hour, and 2 hours 1, 2

Diagnosis requires ANY SINGLE value meeting or exceeding these thresholds: 1

  • Fasting: ≥92 mg/dL (5.1 mmol/L)
  • 1 hour: ≥180 mg/dL (10.0 mmol/L)
  • 2 hours: ≥153 mg/dL (8.5 mmol/L)

This approach identifies approximately 15-20% of pregnant women with GDM, roughly 2-3 times more than the two-step approach 5, 6

Two-Step Approach (ACOG-Supported)

Step 1: Initial Screening

Perform a 50g glucose load test (nonfasting) with plasma glucose measured at 1 hour 1

  • Proceed to diagnostic testing if glucose is ≥130 mg/dL, ≥135 mg/dL, or ≥140 mg/dL 1
  • The 140 mg/dL threshold identifies approximately 80% of GDM cases; lowering to 130 mg/dL increases sensitivity to 90% 1

Step 2: Diagnostic Testing

Perform a 100g OGTT after an overnight fast, measuring plasma glucose at fasting, 1 hour, 2 hours, and 3 hours 1

Diagnosis requires AT LEAST TWO values meeting or exceeding these thresholds (Carpenter-Coustan criteria): 1, 2

  • Fasting: ≥95 mg/dL (5.3 mmol/L)
  • 1 hour: ≥180 mg/dL (10.0 mmol/L)
  • 2 hours: ≥155 mg/dL (8.6 mmol/L)
  • 3 hours: ≥140 mg/dL (7.8 mmol/L)

Important caveat: ACOG recently noted that a single elevated value (rather than two) may be used for diagnosis, which significantly increases GDM incidence with this approach 1, 2, 7

Alternative Criteria (NDDG)

The older National Diabetes Data Group criteria use slightly higher thresholds for the 100g OGTT: fasting ≥105 mg/dL, 1h ≥190 mg/dL, 2h ≥165 mg/dL, 3h ≥145 mg/dL 1

Early Pregnancy Overt Diabetes Diagnosis

If testing at the first prenatal visit reveals fasting plasma glucose ≥126 mg/dL or random glucose ≥200 mg/dL (confirmed on a subsequent day), diagnose overt diabetes rather than GDM 1, 3

Key Clinical Considerations

  • The one-step approach requires all women to fast, making it more burdensome but eliminates the need for a second test 1, 6
  • The two-step approach does not require fasting for initial screening, improving patient convenience and compliance 1
  • Both approaches are acceptable, and the choice depends on your practice setting, patient population prevalence, and available resources 1, 6
  • Do not perform OGTT after bariatric surgery due to risk of postprandial hypoglycemia; use alternative monitoring strategies 3

Postpartum Follow-Up

Test all women with GDM at 4-12 weeks postpartum using a 75g OGTT with non-pregnancy diagnostic criteria to identify persistent diabetes or prediabetes 1, 2, 7

Continue lifelong screening at least every 3 years, as women with prior GDM have a 3.4-fold increased risk of developing type 2 diabetes 1, 2, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis of Gestational Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Gestational diabetes mellitus (Update 2023)].

Wiener klinische Wochenschrift, 2023

Research

One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2020

Guideline

Diagnóstico de Diabetes Gestacional

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Management of Gestational Diabetes Mellitus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.